P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and more, play a significant role in disease-related bacterial presence. This ...

Brooke Abbott Abron faced significant barriers to diagnosis and adequate care for Crohn's disease, rooted in systemic racism ...